Advocates for the Reform of Prescription Opioids
by pjackson on September 3, 2012
Comments on this entry are closed.
Previous post: International Overdose Awareness Day: People’s Lives Matter
Next post: Health Canada should delay approval of generic OxyContin, health ministers say
ARPO does not accept financial support from the pharmaceutical companies or any other entities that could be perceived as a conflict of interest.
Copyright © 2017 ARPO. All rights reserved.